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Abstract
Phthalates are endocrine disrupting compounds commonly found in consumer products, exposure 
to which may influence reproductive maturation. Effects from exposure in utero on the onset and 
progression of sexual development are understudied. We examined longitudinal associations 
between gestational phthalate exposure and sexual maturation at two points in adolescence (8–14, 
9–18 years). Gestational exposure was quantified using the geometric mean of 3 trimester-specific 
urinary phthalate metabolite measurements. Sexual maturation was assessed using Tanner stages 
and menarche onset for girls and Tanner stages and testicular volume for boys. Generalized 
estimating equations for correlated ordinal multinomial responses were used to model 
relationships between phthalates and odds of transitioning to the next Tanner stage, while 
generalized additive (GA) mixed models were used to assess the odds of menarche. All models 
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were adjusted for child age (centered around the mean), BMI z-score, change in BMI between 
visits, time (years) between visits (ΔT), and interactions between ΔT and mean-centered child age 
and the natural log of exposure metabolite concentration. Among girls, a doubling of gestational 
MBzP concentrations was associated with increased odds of being at a higher Tanner stage for 
breast development at 8–14 years (OR=4.62; 95% CI: 1.38, 15.5), but with slower progression of 
breast development over the follow-up period (OR=0.65 per year; 95% CI: 0.46, 0.92) after 
adjustment for child age and BMI z-score. Similar results were found for ΣDEHP levels and breast 
development. In boys, a doubling of gestational MBP concentrations was associated with lower 
odds of being at a higher Tanner stage for pubic hair growth at 8–14 years (OR=0.37; 95% CI: 
0.14, 0.95) but with faster progression (OR: 1.28; 95% CI: 0.97, 1.69). These results indicate that 
gestational phthalate exposures may impact the onset and progression of sexual development, and 
that these relationships differ between boys and girls.
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1. Introduction
Decreasing age at pubertal onset has become an increasingly common global problem in the 
last decade (Aksglaede et al., 2008; Biro and Greenspan, 2013; Herman-Giddens et al., 
2012). Several different mechanisms have been proposed as influencing this trend including 
genetic factors (Elks et al., 2010; Ong et al., 2009; Perry et al., 2014), increasing trends in 
BMI (Aksglaede et al., 2009; Boyne et al., 2010; Buyken et al., 2008; Kleber et al., 2011; 
Lee et al., 2010, 2007; Sørensen et al., 2010), and endocrine disruption (Buck Louis et al., 
2008), but true underlying factors are still poorly understood.
Phthalates are a class of endocrine disrupting compounds commonly used in the 
manufacture of consumer products including food storage containers, medical tubing, and 
personal care products. Exposure to phthalates is widespread in the population (A. M. 
Calafat et al., 2015) and has been linked to numerous adverse health outcomes including 
altered reproductive function throughout the life cycle (Hauser and Calafat, 2005). Exposure 
among pregnant women specifically has been investigated (Arbuckle et al., 2014; 
Cantonwine et al., 2014; Valvi et al., 2015; Zeman et al., 2013) and found to be linked to 
adverse birth outcomes including low birth weight, birth length, head circumference, 
gestational age, and risk of spontaneous abortion and preterm birth (Casas et al., 2016; 
Dereumeaux et al., 2016; Ferguson et al., 2014a, 2016; Ko et al., 2013; Meeker et al., 2009; 
Mu et al., 2015; Peng et al., 2016; Smarr et al., 2015; Toft et al., 2012; Watkins et al., 2016).
Previous research has demonstrated significant associations between sexual maturation 
outcomes and phthalate exposures measured during childhood (Binder et al., 2018; Kasper-
Sonnenberg et al., 2017; A. Mouritsen et al., 2013; Wolff et al., 2014; Zhang et al., 2015) 
and adolescence (Frederiksen et al., 2012; Srilanchakon et al., 2017; Wolff et al., 2010). 
Animal studies have demonstrated that in utero phthalate exposure may lead to a myriad of 
adverse reproductive outcomes, particularly inhibition of testosterone synthesis in the testes 
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among males and reduced fertility among females (X. Chen et al., 2017; Howdeshell et al., 
2008; Hu et al., 2013; Kay et al., 2014; Wang et al., 2016; Zhou et al., 2017), but human 
studies are still lacking. Furthermore, studies that do utilize gestational phthalate exposure 
do not use multiple adolescent follow-up visits to assess influence on the rate of progression 
of sexual development. Previous research coming from the ELEMENT cohort utilized 
gestational phthalate concentrations to assess relationships with odds of onset of sexual 
maturation at 8–14 years, but we now have additional data at a second adolescent follow-up 
visit (ages 9–18 years) that was not available previously (Watkins et al., 2017a, 2017b). 
Therefore, the goal of this analysis was to build on previous ELEMENT work by utilizing 
multiple gestational measures of urinary phthalate biomarkers to test for associations with 
initiation and progression of sexual maturation at two different adolescent follow-up visits.
2. Methods
2.1. Study Population
The present study was conducted as part of the Early Life Exposure in Mexico to 
Environmental Toxicants (ELEMENT) project, a longitudinal pregnancy cohort in Mexico 
City. Women were recruited from 1997 to 2004 during their first trimester from maternity 
hospitals (Lewis et al., 2013). Urine samples were collected and interview-based 
questionnaires were completed by mothers at up to three time points during pregnancy. 
Mean gestational ages, which were estimated based on the self-reported date of last 
menstrual period, were 13.5 weeks (range 9–24 weeks), 25.1 weeks (range 19–37 weeks) 
and 34.4 weeks (range 28–43 weeks) at each visit. A subset of adolescent children from 
these mothers were followed-up over two adolescent study visits, one beginning in 2011 and 
one in 2015, where they provided anthropometry and demographic information. Ages of 
children ranged from 8 to 14 years at the first adolescent visit and 9 to 18 years at the second 
visit (there was not a fixed number of years between study visits). The World Health 
Organization child reference curves for age and sex were used to calculate age-specific BMI 
z-scores (World Health Organization, 2007). The present analysis included children with 
data at both adolescent follow-up visits for at least one pubertal outcome, and whose 
mothers provided at least one urinary phthalate measurement during pregnancy, resulting in 
a final sample size of 103 girls and 91 boys. Among those 103 girls, a total of 2, 16, and 85 
mothers provided urine samples at 1, 2, and 3 gestational visits, respectively. Among those 
91 boys, a total of 9, 10, and 72 mothers provided urine samples at 1, 2, and 3 gestational 
visits, respectively. Supplementary Table 1 shows demographic characteristics of mothers 
included in the present analysis compared to all ELEMENT mothers who had children 
eligible for inclusion this study (N=554). Research protocols were approved by the ethics 
and research committees of the Mexico National Institute of Public Health and the 
University of Michigan, and all participants provided informed consent prior to enrollment.
2.2. Urinary phthalate measurements
Spot urine samples were collected from participants. Samples were frozen, kept at −80°C, 
and transported to the University of Michigan for analysis at NSF International (Ann Arbor, 
MI, USA). Nine phthalate metabolites were measured including monoethyl phthalate 
(MEP), mono-n-butyl phthalate (MnBP), monoisobutyl phthalate (MiBP), monobenzyl 
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phthalate (MBzP), mono-3-carboxypropyl phthalate (MCPP), mono-2-ethylhexyl phthalate 
(MEHP), mono-2-ethyl-5-hydroxyhexyl phthalate (MEHHP), mono-2-ethyl-5-oxohexyl 
phthalate (MEOHP), and mono-2-ethyl-5-carboxypentyl phthalate (MECPP) using isotope 
dilution–liquid chromatography–tandem mass spectrometry (ID–LC–MS/MS), described 
elsewhere (Lewis et al., 2013). A summary measure of DEHP (ΣDEHP) exposure was 
calculated by dividing the concentrations of each metabolite by their molar mass and then 
summing the results. Specific gravity was measured at the time of sample analysis using a 
handheld digital refractometer (Atago Co., Ltd., Tokyo, Japan). All concentrations measured 
below the limit of detection (LOD) were replaced by the LOD/√2.
2.3. Sexual maturation outcome assessment
Tanner stages are measured on a standardized scale from 1 to 5 to indicate various stages of 
sexual maturation, with stage 1 indicating that an individual has not yet initiated 
development, stages 2–4 indicating progression through sexual development, and stage 5 
indicating adulthood (Marshall and Tanner, 1970, 1969). In the present study, Tanner stages 
among all children were determined according to standard methods (Chavarro et al., 2017) 
by two trained physicians. Among girls, breast development was used as an indicator of 
puberty and pubic hair growth was used as an indicator of adrenarche. We utilized self-
reported onset of menarche as an additional indicator of puberty. Among boys, genital 
development was used as an indicator of puberty and pubic hair growth was used as an 
indicator of adrenarche. We utilized testicular volume measurements as an additional 
indicator of puberty. Both right and left testicular volume were measured using an 
orchidometer and the larger of the two measurements was retained. Categories of testicular 
volume were set to ≤3 mL (prepubertal), >3 – 20 mL (peripubertal), and >20 mL 
(adulthood) (Mouritsen et al., 2013).
2.4. Statistical methods
Arithmetic means and standard deviations were calculated for age and BMI at each 
adolescent follow up visit. Total N and percent of the population at each stage of sexual 
maturation, in addition to the mean age and standard deviation at each development stage, 
were determined at each study visit. Phthalate biomarker measurements were natural log 
transformed for subsequent individual analyses. Geometric means were calculated from all 
available phthalate metabolite measurements from multiple trimesters to represent overall 
gestational exposure for each participant. Additional analyses were conducted where we 
stratified results by trimester of phthalate exposure but no notable differences were observed 
(data not shown).
Because two visits were available per participant, methods for correlated outcome data were 
utilized to examine the association between phthalate exposure and sexual development. 
Generalized estimating equations (GEEs) for correlated ordinal multinomial responses with 
an independent correlation structure were used to model relationships between gestational 
phthalate exposure and odds of being at a higher Tanner stage or category of testicular 
volume at baseline (age 8–14 years). Generalized additive mixed models (GAMMs) were 
used to assess the relationship between exposures and the binary menarche outcome at 
baseline. The use of these models allows for examination of both baseline development 
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stages and progression between study visits, and accommodation of intraindividual 
correlation of exposure and outcome variables. Models included time (in years) between first 
and second adolescent follow up visits (ΔT), the natural log of the phthalate metabolite 
concentration, and interaction between ΔT and the natural log of the phthalate metabolite 
concentration. Coefficients from these models were used to estimate (1) the odds of being at 
a higher versus a lower development stage (or menarche yes vs. no) at the initial adolescent 
follow up visit (age 8–14 years) per doubling in gestational phthalate concentration (the 
main effect of the metabolite), and (2) the effects of gestational phthalate exposure on the 
tempo at which individuals progressed through puberty and adrenarche (the interaction term 
between phthalate metabolite concentration and time between study visits). The following 
equations were used to calculate effects estimates and confidence intervals for a doubling in 
phthalate exposure:
Effect Estimates: exp log(2) * βphthalate
95% Confidence Intervals: exp log(2) * βphthalate ± sephthalate
Tempo results are presented as the odds of being at a higher versus a lower development 
stage per year following the initial adolescent visit associated with a doubling in gestational 
phthalate exposure, among those with mean age at the initial adolescent visit. Tempo does 
not refer to the time it takes to progress from one preestablished maturation milestone to 
another, but rather the general amount of progression that occurs in one year. A tempo odds 
ratio greater than 1 indicates that higher phthalate concentrations are associated with a faster 
rate of development, while a tempo odds ratio less than 1 would indicate a slower rate of 
development.
Child age (centered around the mean) and BMI z-score at the first adolescent visit were 
included as covariates, in keeping with previous work published by our group (Watkins et 
al., 2017b) and from a priori knowledge of associations with phthalates (Harley et al., 2017; 
Yang et al., 2017) and sexual maturation (C. Chen et al., 2017; Kaplowitz, 2008; Rosenfield 
et al., 2009). Final models also adjusted for change in BMI between the first and second 
adolescent visits, interaction between mean-centered age at first adolescent visit and ΔT, and 
interaction between ΔT and the natural log of the phthalate metabolite concentration. Other 
covariates that were explored for potential confounding effects included maternal age, 
education level, and socioeconomic status during pregnancy. None of these exploratory 
covariates were associated with both exposures and outcomes and were thus excluded from 
final models. All phthalate metabolites were adjusted for specific gravity before inclusion in 
the model to account for differences in urinary dilution. To address the issue of possible 
false discovery from conducting many comparisons, we calculated q values using the 
Benjamini and Hochberg method (Benjamini and Hochberg, 1995). Each sexual maturation 
outcome was treated as a family of tests (10 tests for each phthalate metabolite per outcome, 
run separately for main effect p-values and tempo p-values). High p-values were viewed as 
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being at a higher risk of being false-positives, and q-values<0.1 were interpreted with greater 
confidence.
3. Results
3.1. Phthalate concentrations through pregnancy
Detailed descriptions of prenatal phthalate exposure distributions among ELEMENT girls 
and boys are published elsewhere (Watkins et al., 2017b, 2017a) and are shown in 
Supplementary Table 2. Briefly, all metabolites except for MiBP were detected in at least 
90% of samples. After adjustment for specific gravity, most median metabolite 
concentrations were higher among women expecting a female than a male child throughout 
gestation. Median concentrations of phthalate metabolites were at their highest in the third 
trimester among girls (except MEP and MECPP) and boys. Intraclass correlation 
coefficients (ICCs) were the highest for MEP and the lowest for MCPP among girls and 
MBzP among boys.
3.2. Sexual progression of the study population
Sexual maturation descriptive statistics over the study duration are shown in Table 1. On 
average, both girls and boys were 10 years old at the first adolescent study visit and just 
under 14 years old at the second visit. Both girls and boys had, on average, slightly lower 
BMI at baseline than age-matched children in other populations (BMI z-scores of 0.87 and 
0.88 among girls and boys, respectively).
Among girls, initiation of breast development occurred earlier than menarche and 
adrenarche, with 28.1% of girls having initiated breast development at the first study visit 
compared to only 18.4% and 15.5% of girls having initiated pubic hair growth and 
menarche, respectively. Similarly, a larger portion of girls had reached sexual maturity 
(Tanner Stage = 5) by the second study visit with respect to breast development (16.7%) 
compared to pubic hair growth (11.8%). The majority of girls progressed 2 stages (N=46) 
for breast development [median(IQR): 2(1)] and 1 stage (N=41) for pubic hair growth 
[median(IQR): 1(1)].
Among boys, the patterns for puberty and adrenarche were more discordant. Adrenarche 
occurred much later than puberty, with only 13.2% of boys having initiated pubic hair 
development by the first study visit, compared to 46.2% of boys having initiated genital 
development and 84.6% of boys having a testicular volume greater than 3 mL. In contrast, a 
larger portion of boys had reached stage 5 by the second study visit with respect to genital 
development (16.5%) compared to pubic hair growth (13.2%). Furthermore, only 70.3% of 
the male population had initiated pubic hair growth by the second study visit. The majority 
of boys progressed 2 stages (N=35) for genital development [median(IQR): 2(1)], 0 or 2 
stages (N=27 and 26, respectively) for pubic hair growth [median(IQR): 2(2)], and 0 or 1 
category (N=47 and 43, resepectively) for testicular volume [median(IQR): 0(1)].
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3.3. Phthalate associations with sexual maturation among girls
Associations between gestational phthalate biomarker concentrations and sexual 
development outcomes among girls are shown in Figure 1 and Supplementary Table 3. A 
doubling of ΣDEHP metabolites was associated with increased odds of being at a higher 
breast development Tanner Stage at the initial study visit (OR: 2.76, 95%CI: 1.09, 6.96), and 
also with reduced tempo of breast development over the study period (OR: 0.76, 95%CI: 
0.58, 1.00). Similar results were found among DEHP metabolites at the initial study visit 
[MECPP (OR: 2.50, 95%CI: 1.03, 6.03), MEHHP (OR: 2.76, 95%CI: 1.07, 7.14), MEOHP 
(OR: 2.90, 95%CI: 1.16, 7.23)], and with MBzP (OR: 4.62, 95%CI: 1.38, 15.5). The tempo 
of breast development over the study period was reduced per each doubling of MBzP, 
MEOHP, MEHHP and ΣDEHP (OR range: 0.62 – 0.76), though not all of these results 
reached statistical significance.
Odds of being at a higher versus a lower Tanner Stage for pubic hair growth at baseline were 
marginally higher with a doubling of gestational MEP concentration (OR: 2.24, 95%CI: 
0.97, 5.14). Odds of having reached menarche by the first study visit were marginally higher 
(OR: 3.86, 95%CI: 0.96, 15.5), and the tempo of progression to menarche was slower (OR: 
0.69, 95%CI: 0.47, 1.02), with a doubling of gestational MBzP concentration.
3.4. Phthalate associations with sexual maturation among boys
Associations between gestational phthalate biomarker concentrations and sexual 
development outcomes among boys are shown in Figure 2 and Supplementary Table 4. A 
doubling of gestational MBP concentration was associated with decreased odds of being at a 
higher Tanner Stage for pubic hair growth among boys at the first study visit (OR: 0.38, 
95%CI: 0.15, 0.97), and with a marginally increased tempo of progression of pubic hair 
growth (OR: 1.27, 95%CI: 0.96, 1.68). Measures of gestational phthalate exposure were 
generally associated with decreased odds of being at a higher Tanner Stage for genital 
development at the first study visit and increased tempo of progression (except MIBP) 
through genital development over the study period, but none of these relationships were 
statistically significant. There were no clear patterns of association between gestational 
phthalate levels and testicular volume.
4. Discussion
We assessed relationships between geometric mean gestational phthalate metabolite 
concentrations, and onset and progression of sexual maturation outcomes among girls and 
boys over two adolescent follow-up visits. Our findings suggest that higher gestational 
exposure to phthalates among females was associated with earlier onset and slower 
progression of sexual development, while the opposite patterns were seen among males (i.e., 
later onset and faster progression). The most marked results were seen with high molecular 
weight phthalate metabolites (MBzP and DEHP metabolites) and breast development in 
girls, and low molecular weight phthalate metabolites (MBP) and pubic hair growth in boys.
This is one of the first studies to assess relationships between gestational phthalate exposure 
and the tempo of sexual maturation progression. Several previous studies have explored 
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associations between onset of puberty and the rate of progression to sexual maturity, and 
most found that those with early onset of puberty progressed to adulthood significantly 
slower than those with late onset of puberty (German et al., 2018; Pantsiotou et al., 2008; 
Vizmanos et al., 2004). This apparent compensatory mechanism may function to ensure that 
age at sexual maturity remains within a normal range. In the present study, we found that 
onset and tempo of sexual maturation outcomes generally showed opposite relationships 
with increasing phthalate exposures, with onset being earlier and tempo being slower among 
girls, and onset being later and tempo being faster among boys. These associations suggest 
that the biological response to increasing phthalate exposures may exacerbate basal trends 
that are seen among individuals with early and late onset of puberty, or that innate 
physiology works to maintain homeostatic conditions by compensating for the effects of 
phthalate exposures.
Gestational urinary biomarkers of phthalate exposure have previously been assessed for 
relationships with sexual development later in life in numerous studies coming from two 
cohorts – ELEMENT and CHAMACOS. Early ELEMENT studies assessed relationships 
between third trimester phthalate measurements and sexual development at a single follow-
up visit at age 8–14 years among girls (Watkins et al., 2014) and boys (Ferguson et al., 
2014b), and found that odds of pubic hair growth were generally increased among girls and 
reduced among boys with greater gestational phthalate exposures. Subsequent ELEMENT 
studies examined measures of phthalate exposure across gestation in relation to odds of 
onset of sexual development in girls (Watkins et al., 2017b) and boys (Watkins et al., 2017a). 
Their results suggested that higher gestational exposure to MEP was associated with greater 
odds of initiation of menarche, higher gestational exposure to MEHP was associated with 
decreased odds of initiation of breast development, and higher gestational exposure to MBzP 
was inversely associated with odds of initiating pubic hair growth in boys. Except for MEHP 
and breast development, the direction of associations found in our study were consistent to 
those found previously, though not statistically significant. The majority of our study 
population had initiated sexual development by the second follow-up visit and thus the 
stages of development were more evenly distributed across participants compared to the first 
visit. This allowed us to utilize a statistical model which takes advantage of the ordinal 
nature of Tanner Stage outcomes in the present work, while former studies were only able to 
assess odds of initiating development (Tanner Stage > 1) versus not (Tanner Stage = 1).
Multiple studies looking at gestational phthalate exposure relationships with sexual 
maturation outcomes have come from the CHAMACOS birth cohort in southern California 
(N = 179 girls and 159 boys). Urine samples were taken at two time points during pregnancy 
(mean 14 and 26.9 weeks) to measure metabolite concentrations of high (Berger et al., 2018) 
and low molecular weight (Harley et al., 2019) phthalates, and the geometric mean of these 
concentrations was used as an overall measure of gestational phthalate exposure. Children 
were followed to assess sexual development outcomes every 9 months between the ages of 9 
and 13 years, and results were presented as the adjusted mean shift in age at onset of each 
sexual maturation outcome. Some results in the current study were consistent with those 
seen in the CHAMACOS cohort, including associations between gestational MEP exposure 
and earlier onset of pubic hair growth in girls, and between gestational MBzP and ΣDEHP 
metabolites and earlier onset of breast development in girls. However, various additional 
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associations were found in the CHAMACOS studies that were not observed in our study. 
Sexual development stages were generally reached at a later age among ELEMENT girls 
compared to CHAMACOS girls, and distributions of some phthalate metabolite 
concentrations were different between ELEMENT and CHAMACOS, including those of 
several DEHP metabolites (median concentrations of MEHP, MEHHP, and MECPP were 
higher in ELEMENT), which may have contributed to differences in results. Additionally, 
the participants in the CHAMACOS cohort reside in a community where pesticide exposure 
is high (Castorina et al., 2003), reducing the generalizability of the results. Lastly, the 
CHAMACOS study utilized accelerated failure time models (AFTs) which accommodate 
data with outcomes occurring before or between follow-up visits, but do not allow for 
estimation of the rate of sexual maturation.
An additional study conducted in Australia looked at associations between maternal serum 
concentrations of phthalate metabolites during pregnancy and measures of reproductive 
development in female children of those mothers (Hart et al., 2014). They found marginally 
significant increased odds of onset of menarche with an increasing sum of MEHP and 
MECPP concentrations, results that were not seen in our study. Differences in methodology 
including their use of serum phthalate measurements instead of the preferred urinary 
measurements (A. Calafat et al., 2015; Johns et al., 2015), pooling of gestational serum 
samples rather than using repeated measures, and introduction of recall bias from asking 
participants to recall at what age they initiated menarche (Dorn et al., 2013), may have 
contributed to differing results between our studies. Lastly, a study conducted in Taiwan 
measured third trimester phthalate concentrations and tested for associations with various 
indicators of sexual development later in life (Su et al., 2015). Most outcomes assessed were 
not consistent with those measured in our study, and children were only followed until 11 
years of age when most of them likely had not reached sexual maturity.
Although mechanisms of potential phthalate disruption on sexual development are poorly 
understood, female rodent studies have shown that exposure to DEHP at various times 
through the life cycle can alter estradiol concentrations, possibly via upstream deregulation 
of FSH synthesis or cholesterol transport (Brehm et al., 2017; Davis et al., 1994; Hirosawa 
et al., 2006; Ma et al., 2006; Moyer and Hixon, 2012; Svechnikova et al., 2007). An increase 
in estradiol concentration is necessary for initiation of enlargement of breast tissue (DiVall 
and Radovick, 2009), thus these animal studies point to the need to study estrogen disruption 
as being on the causal pathway from phthalate exposure to altered sexual development.
Our finding that MBP was inversely associated with onset of pubic hair growth in boys 
suggests that phthalates may have the capacity to disrupt adrenal function. In order for pubic 
hair growth to begin, DHEA-S from the adrenal gland must travel to target tissues where 
hair follicles and dermal exocrine glands possess the necessary enzymes to convert DHEA-S 
into dihydrotestosterone (Auchus and Rainey, 2004). Thus is it local synthesis of 
testosterone from upstream adrenal regulation, not circulating androgens, that are critical for 
the initiation of pubic hair growth. Previous animal studies have suggested that in utero 
phthalate exposure can alter expression of adrenal transcription factors (Lee et al., 2016), 
reduce serum aldosterone concentrations (Martinez-Arguelles et al., 2011), and down-
regulate expression of genes required for cholesterol transport and steroid synthesis 
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(Saillenfait et al., 2013), all possible mechanisms by which phthalates may interfere with 
adrenal regulation of pubic hair growth.
The present study had several limitations. Though we measured phthalate metabolite 
concentrations at up to three time points during pregnancy, phthalates are relatively short 
lived inside the body (Braun et al., 2012; Johns et al., 2015) and thus three measurements 
may not fully characterize overall gestational exposure. We also did not adjust for adolescent 
phthalate exposure which could have confounded our results. Additionally, phthalate 
exposure always occurs as a mixture of metabolites and we did not adjust for concurrent 
phthalate exposures. It is possible that BMI acts as a mediator on the causal pathway 
between prenatal phthalate exposure and sexual development, thus our adjustment for BMI 
at baseline and change in BMI between study visits may have introduced bias to our results. 
We were not able to begin follow-up before all children initiated puberty, nor were we able 
to conduct numerous visits thereafter, and thus the exact timing of initiation and progression 
of maturation from one stage to the next cannot be known. However, the majority of our 
population had initiated sexual maturation by the second follow-up visit which allowed us to 
more reliably measure onset and tempo of progression. This builds on previous work from 
the ELEMENT cohort because we have multiple measures of maturation outcomes. Lastly, 
our sample size was relatively small and thus our statistical power to detect true associations 
may be limited.
5. Conclusions
Our results suggest that gestational phthalate exposure is associated with earlier onset and 
slower progression of sexual maturation outcomes in girls, particularly breast development. 
Conversely, gestational phthalate exposure was associated with later onset and faster 
progression of sexual maturation outcomes in boys, though most associations did not reach 
statistical significance. Some of our results align with those of previous studies, but our 
study is methodologically unique. More studies looking at phthalate effects on tempo of 
sexual maturation among a larger sample of children with more frequent follow-up visits are 
needed to substantiate our results. Future research will also utilize longitudinal hormone 
measurements through adolescence to test for possible interactions between hormones and 
phthalates and the resulting impacts on sexual development.
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Highlights
• High molecular weight phthalates were associated with later onset of breast 
growth
• A low molecular weight phthalate was associated with early onset of male 
pubic hair
• Trends of onset and tempo of development were generally in opposite 
directions
• Significant metabolites and directions of associations differed between sexes
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Figure 1: Among girls, the odds of being at a higher tanner stage or menarche at the first 
adolescent study visit and the tempo of sexual maturation progression, with a doubling in 
gestational phthalate exposure (N=103).
* Baseline estimates correspond to effects at the first follow-up visit at 8–14 years of age. 
Tempo estimates correspond to effects per year following the initial study visit.
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Figure 2: Among boys, the odds of being at a higher tanner stage or testicular volume category 
at the first adolescent study visit and the tempo of sexual maturation progression, with a 
doubling in gestational phthalate exposure (N=91).
* Baseline estimates correspond to effects at the first follow-up visit at 8–14 years of age. 
Tempo estimates correspond to effects per year following the initial study visit.
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Table 1:
Outcome descriptive statistics among boys and girls at two adolescent follow-up visits
Girls (N=103)
Visit 1 Visit 2
Mean (sd) N (%) Mean Age (sd) Mean (sd) N (%) Mean Age (sd)
Age (years) 9.98 (1.52) 13.3 (1.63)
ΔT (years)* --- 3.40 (0.400)
BMI 19.4 (3.59) 21.8 (4.10)
BMI - z Score 0.870 (1.25) ---
ΔBMI --- 2.35 (1.93)
Breast Development Tanner Stage
1 74 (71.9%) 9.31 (0.960) 5 (4.90%) 11.5 (0.350)
2 16 (15.5%) 10.9 (1.36) 12 (11.8%) 12.2 (0.850)
3 11 (10.7%) 12.6 (0.470) 45 (44.1%) 12.7 (1.10)
4 2 (1.90%) 13.0 (0.500) 23 (22.5%) 13.8 (1.61)
5 0 --- 17 (16.7%) 15.5 (1.11)
Pubic Hair Tanner Stage
1 84 (81.6%) 9.42 (1.01) 9 (8.80%) 11.6 (0.490)
2 14 (13.5%) 12.2 (0.730) 38 (37.2%) 12.6 (1.05)
3 4 (3.90%) 13.0 (0.440) 26 (25.5%) 13.3 (1.43)
4 1 (1.00%) 13.3 (NA) 17 (16.7%) 14.3 (1.60)
5 0 --- 12 (11.8%) 15.5 (1.16)
Menarche
No 87 (84.5%) 9.51 (1.13) 23 (22.5%) 12.1 (0.850)
Yes 16 (15.5%) 12.5 (0.610) 79 (77.5%) 13.6 (1.60)
Boys 1 N=91)
P20 P01
Mean (sd) N (%) Mean Age (sd) Mean (sd) N (%) Mean Age (sd)
Age (years) 10.2 (1.52) 13.5 (1.70)
ΔT (years)* --- 3.32 (0.440)
BMI 18.9 (3.08) 20.4 (3.85)
BMI - z Score 0.880 (1.22) ---
ΔBMI --- 1.53 (1.71)
Genital Development Tanner Stage
1 49 (53.8%) 9.41 (1.00) 7 (7.70%) 11.8 (0.390)
2 33 (36.3%) 10.5 (1.34) 17 (18.7%) 12.4 (0.820)
3 8 (8.80%) 12.9 (0.540) 22 (24.1%) 12.5 (1.10)
4 1 (1.10%) 13.2 (NA) 30 (33.0%) 14.0 (1.28)
5 0 --- 15 (16.5%) 15.9 (1.13)
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Pubic Hair Tanner Stage
1 79 (86.8%) 9.80 (1.25) 27 (29.7%) 12.0 (0.79)
2 10 (11.0%) 12.6 (0.70) 15 (16.5%) 12.8 (1.01)
3 2 (2.20%) 12.6 (0.920) 25 (27.5%) 13.6 (1.19)
4 0 --- 12 (13.2%) 15.0 (1.46)
5 0 --- 12 (13.2%) 15.8 (1.23)
Testicular Volume
[0, 3] 14 (15.4%) 9.29 (0.930) 0 ---
(3,20] 76 (83.5%) 10.3 (1.51) 59 (64.8%) 12.7 (1.20)
(20, 25] 1 (1.10%) 13.8 (NA) 32 (35.2%) 15.0 (1.51)
*
Refers to the time, in years, between visits 1 and 2.
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